NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Does Near‑24 Hour Trading Access Shift the Long‑Term Innovation Narrative for Nasdaq (NDAQ)?

Nasdaq, Inc. recently moved to extend U.S. equity trading to 23 hours a day on its venues, filing with the SEC for an additional overnight session and outlining operational readiness for the expanded schedule by 2026. This push toward near-continuous trading highlights Nasdaq’s effort to reshape access to U.S. markets, particularly for global and after-hours investors, while reinforcing its identity as a technology-driven market operator. We’ll now explore how Nasdaq’s 23-hour trading push...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Assessing Ocular Therapeutix (OCUL) Valuation After Accelerated FDA Filing Plan for AXPAXLI in Wet AMD

Ocular Therapeutix (OCUL) just sped up the playbook for its lead eye drug by planning to file an FDA application for AXPAXLI in wet AMD based on positive year one SOL-1 Phase 3 data. See our latest analysis for Ocular Therapeutix. The pivot to an earlier NDA comes as Ocular Therapeutix trades at $13.72, with a 1 month share price return of 16.67 percent and a year to date share price return of 56.98 percent, while its 3 year total shareholder return of 395.31 percent signals strong long term...
NasdaqCM:SSII
NasdaqCM:SSIIMedical Equipment

SS Innovations International (SSII): Valuation Check After Key 510(k) FDA Filing for SSi Mantra Surgical Robot

SS Innovations International (SSII) just hit a key milestone by filing a 510(k) submission with the FDA for its SSi Mantra surgical robot, aiming for faster, potentially lower cost entry into the US market. See our latest analysis for SS Innovations International. That progress comes after a choppy run, with a 1 day share price return of 6.7 percent and a 1 year total shareholder return of 17.4 percent suggesting momentum is starting to rebuild from a lower base. If this kind of medtech story...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

How Investors May Respond To IDEAYA Biosciences (IDYA) Regaining Oncology Programs After GSK Collaboration Exit

Earlier in December 2025, GlaxoSmithKline notified IDEAYA Biosciences that it will terminate their 2020 collaboration and license agreement, returning the Werner Helicase (IDE275) and Pol Theta (IDE705) clinical programs to IDEAYA within about 90 days. This shift hands IDEAYA full control of two oncology assets while the company maintains its guidance that cash resources should last into 2030. Next, we’ll examine how GSK’s exit from the collaboration reshapes IDEAYA’s investment narrative,...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Is It Too Late To Consider Ally After Its 106% Three Year Surge?

Wondering if Ally Financial at around $44 a share is still a value play after its big run, or if most of the upside is already priced in, you are not alone. The stock has climbed 18.4% over the last month, 24.8% year to date, and an impressive 106.8% over three years, which naturally raises questions about how much of the future has been pulled forward. Recent headlines have focused on Ally sharpening its digital banking strategy and doubling down on auto and consumer lending, while also...
NYSE:LEN
NYSE:LENConsumer Durables

Lennar (LEN) Q4: Net Margin Drop to 6.1% Tests Asset‑Light Bull Case

Lennar (LEN) has just wrapped up FY 2025 with fourth quarter revenue of about $9.4 billion and basic EPS of $1.94, setting the tone for a year in which trailing twelve month revenue came in at roughly $34.2 billion alongside EPS of $8.06. The company has seen quarterly revenue move from around $9.9 billion in Q4 2024 to $9.4 billion in Q4 2025, while basic EPS shifted from $4.06 to $1.94 over the same stretch, leaving investors focused on how much of that topline scale is now flowing through...
NasdaqGS:COMM
NasdaqGS:COMMCommunications

CommScope (COMM): Evaluating Valuation After a 2,444% Year-to-Date Share Price Rebound

CommScope Holding Company (COMM) has quietly staged a sharp turnaround, with shares up about 2,444% year to date and nearly 1,900% over the past year, catching many investors off guard. See our latest analysis for CommScope Holding Company. That surge has cooled a bit recently, with a 7 day share price return of negative 11.77 percent and a 30 day share price return of 7.63 percent. However, the 1 year total shareholder return of 189.89 percent still points to powerful momentum as investors...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Has the Market Run Too Far Ahead of Huntington After Its Strong Five Year Rally?

Wondering whether Huntington Bancshares is still a buy at today's price, or if the easy gains are already behind it? This breakdown will help you decide, using a clear, valuation-first lens. After a solid run, the stock is up 15.6% over the last month and 15.9% over the past year, adding to a 79.4% gain over five years that has investors asking if it is getting ahead of itself. Recent headlines have focused on Huntington's continued push to grow its regional footprint and deepen customer...
NYSE:POR
NYSE:PORElectric Utilities

Portland General Electric (POR) Valuation Check After New Groundwater Contamination Lawsuit in Oregon

Portland General Electric (POR) just got hit with a fresh lawsuit in Oregon accusing it of contributing to nitrate contaminated groundwater, a legal twist that could reshape how investors think about the utility’s long term risk profile. See our latest analysis for Portland General Electric. Even with this legal overhang, the stock’s 90 day share price return of 15.4 percent and 1 year total shareholder return of 18.1 percent suggest investors still see improving prospects rather than fading...
OTCPK:NTDT.Y
OTCPK:NTDT.YIT

NTT DATA Group (OTCPK:NTDT.Y): Valuation Check After New AI Subsidiary, CEO Appointment and Cybersecurity Expansion

NTT DATA Group (OTCPK:NTDT.Y) just laid out a clear AI playbook by spinning up NTT DATA AIVista in Silicon Valley, naming seasoned AI executive Dr. Bratin Saha as CEO, and doubling down on AI driven cyber and data center capacity. See our latest analysis for NTT DATA Group. Investors are clearly noticing this AI and infrastructure push, with the share price up 8.33% over the last week and a 2025 year to date share price return of 37.42 percent, adding to an already strong multi year total...
NasdaqGS:HAS
NasdaqGS:HASLeisure

How Investors May Respond To Hasbro (HAS) Leaning on Wizards Profit as Toys Take a Back Seat

In December 2025, 37GAMES concluded its year-long TRANSFORMERS collaboration in mobile title Puzzles & Survival, while Hasbro-supported franchises like Magic: The Gathering and Dungeons & Dragons drew fresh attention through digital initiatives, new product waves, and analyst commentary. The news highlights how Hasbro’s pivot toward higher-margin games and intellectual property, with Wizards of the Coast now generating over 80% of operating profit, is reshaping the business away from...
NasdaqGS:DMLP
NasdaqGS:DMLPOil and Gas

Should Dorchester Minerals’ (DMLP) Leadership Shuffle Recast Its Long‑Term Governance and Capital Allocation Story?

Dorchester Minerals, L.P. announced that long-time leader and co-founder William Casey McManemin will retire from the Board of Managers effective December 31, 2025, with Robert C. Vaughn serving as Interim Chairman and Albert G. Nance III joining the board from January 1, 2026. By naming McManemin Chairman Emeritus while elevating fellow co-founder Vaughn and adding industry veteran Nance, the partnership is signaling an emphasis on continuity of governance alongside fresh oil and gas...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Assessing Axon Enterprise After a 317.2% Five Year Surge and Recent Pullback

Wondering if Axon Enterprise is still worth buying after its massive run over the last few years, or if the easy money has already been made? You are not alone. The stock has cooled off recently, with shares down 3.2% over the last week and about 7.8% year to date, but that is after a gain of 214.8% over three years and 317.2% over five years. Investors have been reacting to Axon's expanding footprint in public safety technology, from its TASER devices to body cameras and cloud based...
NYSE:RCL
NYSE:RCLHospitality

How A US$2 Billion Buyback And Higher Dividend At Royal Caribbean (RCL) Has Changed Its Investment Story

Royal Caribbean Group’s board recently declared a quarterly dividend of US$1.00 per share, payable on January 14, 2026 to shareholders of record on December 26, 2025, and authorized a new share repurchase program of up to US$2.00 billion. These shareholder returns arrive shortly after a mixed third-quarter update and softer earnings guidance, highlighting management’s confidence despite recent operational and sentiment challenges. Next, we’ll explore how the new US$2.00 billion buyback...
NYSE:SMR
NYSE:SMRElectrical

Assessing NuScale Power’s Premium Valuation After Recent Share Price Slide

Wondering if NuScale Power at around $15.73 is a bargain or a value trap? This article will walk through what the numbers are really saying about the stock. The share price has been under pressure recently, down 22.6% over the last week and 25.3% over the past month. However, it is still up 53.5% over 3 years and 52.0% over 5 years, hinting at a volatile but resilient story. Much of the recent move has been shaped by shifting sentiment around small modular reactors, including policy support...
NasdaqCM:ABTC
NasdaqCM:ABTCSoftware

Does American Bitcoin’s Sharp 2025 Share Price Slump Signal a Long Term Opportunity?

Many investors are asking whether American Bitcoin at around $1.65 is a bargain or a value trap, so here is a breakdown of what the market might be missing. The stock has been extremely volatile recently, dropping about 14.9% over the last week and sliding roughly 67.3% over the past month, leaving it down around 74.3% year to date. Those sharp moves are coming as crypto related names remain highly sensitive to shifts in risk appetite and sentiment around digital asset regulation, with...
NYSE:KTB
NYSE:KTBLuxury

Is Kontoor Brands Now a Value Opportunity After 2025 Pullback and DCF Reassessment

If you have been wondering whether Kontoor Brands is quietly turning into a value opportunity, you are not alone. This stock is starting to look interesting for valuation focused investors. Despite being down 6.2% over the last week, 8.1% over the past month, and 24.8% year to date, the stock is still up 80.7% over 3 years and 83.6% over 5 years, which indicates that long term holders have done well even after the recent pullback. Recently, sentiment around apparel and denim names has been...
NasdaqGS:EXE
NasdaqGS:EXEOil and Gas

Is Expand Energy (EXE) Turning Merger Synergies Into a More Durable Earnings Engine?

In recent months, Expand Energy, formed by the 2024 merger of Chesapeake Energy and Southwest Energy, reported a surge in oil, natural gas, and natural gas liquids sales, supported by stronger marketing revenues and derivatives contributions. These operational gains, building on merger-driven efficiencies, highlight how the company’s scale and cost reductions are starting to translate into materially stronger commercial performance. We’ll now explore how this surge in energy product sales...
NYSE:JBL
NYSE:JBLElectronic

Is It Too Late To Consider Jabil After Its Remarkable Multi Year Share Price Surge

If you are wondering whether Jabil’s roaring share price still leaves any real value on the table, you are not alone, and this is exactly what we are going to unpack. Despite a recent 5.9% pullback over the last week, the stock is still up 7.9% over the past month, 51.4% year to date, and 50.8% over the last year, building on gains of 210.1% in 3 years and 408.7% in 5 years. That kind of run has been underpinned by Jabil’s strategic pivot toward higher margin, technology focused...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Is Cisco (CSCO) Using Employee Stock Plans to Quietly Reinforce Its AI Infrastructure Ambitions?

Cisco Systems recently filed two shelf registrations totaling about US$14.05 million, covering 177,212 common shares for employee stock ownership plan offerings. These ESOP-related registrations highlight Cisco’s ongoing use of equity-based compensation, aligning employees more closely with the company’s AI-focused growth initiatives and performance. We’ll now examine how Cisco’s employee share offerings interact with its AI infrastructure momentum and evolving investment narrative. AI is...
NYSE:ORA
NYSE:ORARenewable Energy

Has Ormat Technologies Recent 57.4% Surge in 2025 Already Priced In Its Growth Story

Wondering if Ormat Technologies is still a smart buy after its big run, or if the easy money has already been made? You are not alone, and that is exactly what we are going to unpack here. Despite a soft patch in the last week with the stock down 3.8%, Ormat is still up 1.1% over the past month and 57.4% year to date, translating to a 62.9% gain over the last year. That surge has come as investors have doubled down on clean energy names like Ormat, which develops and operates geothermal and...
NYSE:LEU
NYSE:LEUOil and Gas

Centrus Energy (LEU) Expansion in Piketon: How the New Facility Shapes the Stock’s Nuclear Growth Valuation

Centrus Energy (LEU) just took a concrete step in its Piketon, Ohio expansion, kicking off design work for a large Training, Operations and Maintenance facility that could anchor future uranium enrichment growth. See our latest analysis for Centrus Energy. The Piketon buildout comes after a huge run in Centrus, with the share price still around $221.45 despite a sharp recent pullback and a powerful multi year total shareholder return that suggests long term momentum is intact even as near...
NYSE:AJG
NYSE:AJGInsurance

Reassessing Arthur J. Gallagher’s Valuation After Recent Share Price Pullback in 2025

If you have ever wondered whether Arthur J. Gallagher at around $250 a share is still a buy or finally priced for perfection, you are in the right place. The stock has slipped about 3.2% over the last month and is down 9.1% year to date, even after a modest 4.3% rebound over the past week, which hints that market sentiment has been wobbling despite a strong 115.1% gain over five years. Recently, the company has stayed in the spotlight as investors focus on the resilience of insurance brokers...
NYSE:SN
NYSE:SNConsumer Durables

Does SharkNinja’s Recent 33.5% Rally Still Leave Room for Long Term Upside?

Wondering if SharkNinja is still a smart buy after its big run, or if the price has already baked in the growth story? In this article, we unpack what the current share price is really saying about future expectations. SharkNinja has been on a strong short term rally, with the stock up 33.5% over the last month and 16.5% year to date, even though it dipped slightly by 0.2% in the last week. Part of this momentum has come as investors react to SharkNinja's expanding product lineup in home...